Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP(3)R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3
Publication

Publications

Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP(3)R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3

Title
Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP(3)R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3
Type
Article in International Scientific Journal
Year
2023
Authors
Cunha-Garcia, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Monteiro-Fernandes, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Correia, JS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Neves-Carvalho, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Vilaca-Ferreira, AC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Guerra-Gomes, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Viana, JF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Oliveira, JF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Teixeira-Castro, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maciel, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Duarte-Silva, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 24 No. 2335
ISSN: 1661-6596
Publisher: MDPI
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-00Y-R9F
Abstract (EN): Spinocerebellar ataxia type 3 (SCA3) is a rare neurodegenerative disease caused by an abnormal polyglutamine expansion within the ataxin-3 protein (ATXN3). This leads to neurodegeneration of specific brain and spinal cord regions, resulting in a progressive loss of motor function. Despite neuronal death, non-neuronal cells, including astrocytes, are also involved in SCA3 pathogenesis. Astrogliosis is a common pathological feature in SCA3 patients and animal models of the disease. However, the contribution of astrocytes to SCA3 is not clearly defined. Inositol 1,4,5-trisphosphate receptor type 2 (IP(3)R2) is the predominant IP3R in mediating astrocyte somatic calcium signals, and genetically ablation of IP(3)R2 has been widely used to study astrocyte function. Here, we aimed to investigate the relevance of IP(3)R2 in the onset and progression of SCA3. For this, we tested whether IP(3)R2 depletion and the consecutive suppression of global astrocytic calcium signalling would lead to marked changes in the behavioral phenotype of a SCA3 mouse model, the CMVMJD135 transgenic line. This was achieved by crossing IP(3)R2 null mice with the CMVMJD135 mouse model and performing a longitudinal behavioral characterization of these mice using well-established motor-related function tests. Our results demonstrate that IP(3)R2 deletion in astrocytes does not modify SCA3 progression.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 22
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Vanadium Compounds with Antidiabetic Potential (2023)
Another Publication in an International Scientific Journal
Amaral, LMPF; Moniz, T; Silva, AMN; Maria Rangel
Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis (2019)
Another Publication in an International Scientific Journal
Ferreira, N; Maria Joao Saraiva; Almeida, MR
Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems (2019)
Another Publication in an International Scientific Journal
Souto, EB; Dias Ferreira, J; Oliveira, J; Sanchez Lopez, E; Lopez Machado, A; Espina, M; Garcia, ML; Souto, SB; Martins Gomes, C; Silva, AM
Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents-A Review (2024)
Another Publication in an International Scientific Journal
Coimbra, S; Rocha, S; Sousa, NR; Cristina Catarino; Belo, L; Bronze da Rocha, E; Valente, MJ; Santos-Silva, A
Therapeutic Approaches for Age-Related Macular Degeneration (2022)
Another Publication in an International Scientific Journal
Galindo-Camacho, RM; Blanco-Llamero, C; da Ana, R; Fuertes, MA; Senorans, FJ; Silva, AM; Garcia, ML; Souto, EB

See all (285)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-09-24 at 03:17:23 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book